Form4insider filings, from the source

SEC Form 4 · accession 0001645627-18-000047

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Aug 15, 2018
Accepted (ET)
Aug 22, 2018 · 2:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockAug 15, 2018P2,000$0.0208A25,569,198D
Common StockAug 15, 2018P2,000$0.0205A25,571,198D
Common StockAug 15, 2018P1,000$0.0202A25,572,198D
Common StockAug 15, 2018P2,000$0.0202A25,574,198D
Common StockAug 15, 2018P2,000$0.0208A25,576,198D
Common StockAug 15, 2018P2,000$0.021A25,578,198D
Common StockAug 15, 2018P2,000$0.0208A25,580,198D
Common StockAug 15, 2018P5,000$0.0208A25,585,198D
Common StockAug 15, 2018P1,000$0.0198A25,586,198D
Common StockAug 15, 2018P2,000$0.02A25,588,198D
Common StockAug 15, 2018P2,000$0.02A25,590,198D
Common StockAug 15, 2018P1,000$0.0209A25,591,198D
Common StockAug 15, 2018P2,000$0.0222A25,593,198D
Common StockAug 15, 2018P5,000$0.0222A25,598,198D
Common StockAug 15, 2018P2,000$0.0285A25,600,198D
Common StockAug 15, 2018P2,000$0.0285A25,602,198D
Common StockAug 16, 2018P2,000$0.0246A25,604,198D
Common StockAug 16, 2018P2,000$0.0246A25,606,198D
Common StockAug 16, 2018P5,000$0.024A25,611,198D
Common StockAug 16, 2018P2,000$0.0274A25,613,198D
Common StockAug 16, 2018P2,000$0.029A25,615,198D
Common StockAug 16, 2018P5,000$0.0219A25,620,198D
Common StockAug 16, 2018P2,000$0.0267A25,622,198D
Common StockAug 16, 2018P2,000$0.0255A25,624,198D
Common StockAug 16, 2018P2,000$0.0237A25,626,198D
Common StockAug 16, 2018P2,000$0.025A25,628,198D
Common StockAug 16, 2018P5,000$0.0244A25,633,198D
Common StockAug 16, 2018P1,000$0.0244A25,634,198D

Table II — derivative securities

No Table II lines on this filing.